cyclosporine and Myocardial Ischemia

cyclosporine has been researched along with Myocardial Ischemia in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	16 (30.19)	18.2507
2000's	24 (45.28)	29.6817
2010's	13 (24.53)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, SW; Sciuto, KJ; Venable, PW; Warren, JS; Warren, M; Zaitsev, AV	1
Alhenc-Gelas, F; Belaidi, E; Clemessy, M; Fazal, L; Ovize, M; Pizard, A; Richer, C; Vincent, MP; Waeckel, L; Youcef, G; Zadigue, G	1
Jia, DL; Li, WN; Lv, Y; Shu, WQ; Wu, N	1
Chin, KY; May, L; Qin, C; Ritchie, RH; Woodman, OL	1
Behmenburg, F; Blase, D; Dorsch, M; Grievink, H; Heinen, A; Hollmann, MW; Huhn, R; Raible, M	1
Cai, J; Chen, ML; Chi, HJ; Dong, JL; Lin, XM; Qi, D; Sun, H; Yang, XC; Zhao, WS	1
Mathew, AK; Raghu, KG; Reshma, PL; Sainu, NS	1
Gorman, JH; Gorman, RC; Hinmon, R; Kanemoto, S; Leshnower, BG; Matsubara, M; Sakamoto, H	1
Chambers, DJ	1
Chen, YS; Chi, NH; Chou, NK; Huang, SC; Ko, WJ; Sun, CD; Tsao, CI; Wang, CH; Wang, SS; Wu, IH; Yu, HY	1
Chen, L; Gong, Q; Knowlton, AA; Stice, JP	1
Arbustini, E; Narula, J	1
Chance, B; Gorman, JH; Gorman, RC; Leshnower, BG; Matsubara, M; Noma, M; Ranji, M; Ratcliffe, SJ	1
Alderson, JM; Clements-Jewery, H; Hatcher, AS	1
Akutagawa, T; Furukawa, T; Hasada, K; Hotta, Y; Mitsui-Saitoh, K; Mizutani, H; Niwa, M; Sugimoto, Y; Takaya, Y; Yamada, J	1
Boston-Griffiths, EA; Hausenloy, DJ; Yellon, DM	1
Ruiz-Meana, M	1
Baxter, GF; Hausenloy, DJ; Maddock, HL; Yellon, DM	1
Akopova, OV; Sahach, VF; Strutyns'ka, NA; Vavilova, HL	1
Borutaite, V; Brown, GC; Jekabsone, A; Morkuniene, R	1
Cantin, B; Chan, MC; Hunt, SA; Kwok, BW; Shiba, N; Valantine, HA	1
Berkich, DA; LaNoue, KF; Salama, G	1
Duchen, M; Hausenloy, D; Wynne, A; Yellon, D	1
Argaud, L; Chiari, P; Gateau-Roesch, O; Gueugniaud, PY; Lehot, JJ; Loufouat, J; Muntean, D; Ovize, M; Piriou, V; Salles, D	1
Argaud, L; Gateau-Roesch, O; Loufouat, J; Ovize, M; Raisky, O; Robert, D	1
Bruce, IC; Cao, CM; Gao, Q; Xia, Q; Zhang, SZ	1
Fukushima, T; Hirose, Y; Kang, Y; Kashiwaba, M; Kawabata, H; Masaki, H; Miyairi, Y; Satoh, A; Shimoyama, K; Wano, Y	1
Abellán, A; Garcia-Dorado, D; Miró-Casas, E; Ruiz-Meana, M; Soler-Soler, J	1
Andrés, A; Arias, M; Domínguez, B; Fernández-Fresnedo, G; Fernández-Juárez, G; Marcén, R; Morales, JM; Ortuño, J; Pascual, J; Rodrigo, E	1
Davidson, SM; Hausenloy, DJ; Lim, SY; Yellon, DM	1
Xie, JR; Yu, LN	1
Griffiths, EJ; Halestrap, AP	2
Breckenridge, C; Gault, MH; Harnett, J; Longerich, LL; Purchase, L	1
Cabrol, C; Cacoub, P; Carayon, A; Dorent, R; Gandjbakhch, I; Godeau, P; Golmard, JL; Nataf, P; Vaissier, E	1
Cavero, PG; Chatterjee, K; DeMarco, T; Galli, F; Keith, F; Sudhir, K	1
Bors, V; Cabrol, A; Cabrol, C; Dorent, R; Gandjbakhch, I; Leger, P; Levasseur, JP; Nataf, R; Pavie, A; Vaissier, E	1
Bond, S; Bowers, MC; Cardy, A; Copeland, JG; Gatewood, LB; Larson, DF; Sethi, GK	1
David, M; Gabrielle, F; Maupoil, V; Mossiat, C; Rochette, L; Tatou, E	1
Becker, BF; Gerlach, E; Kupatt, C; Massoudy, P; Reder, E; Zahler, S	1
Albengres, E; Berland, Y; Crevat, A; d'Athis, P; Hestin, D; Jaber, K; Kessler, M; Olivier, P; Roux, F; Simon, N; Tillement, JP	1
Arras, M; Doll, R; Eckert, P; Mohri, M; Schaper, J; Schaper, W; Strasser, R	1
Bellón, JM; Buján, J; Golitsin, A; Jurado, F; Millán, L; Pareja, JA; Pascual, G	1
Veness, MJ	1
Loertscher, R	1
Cohen, MV; Downey, JM; Liu, GS; Weinbrenner, C	1
Carrier, M; Daly, P; Davies, R; Gudas, V; Kostuk, W; Latter, D; Rivard, M; Sullivan, J; Teo, K; White, M	1
Condorelli, G; De Windt, LJ; Dorn, GW; Kitsis, RN; Lim, HW; Molkentin, JD; Taigen, T; Wencker, D	1
Minners, J; Opie, LH; Sack, MN; Schwalb, H; van den Bos, EJ; Yellon, DM	1
Barile, M; Bernardi, P; Canton, M; Di Lisa, F; Menabò, R	1
Kunst, H; Madden, B; Paruchuru, PK	1
Berry, GJ; Boeke, K; Hausen, B; Morris, RE	1
Reis, F; Ribeiro, CA; Tavares, P; Teixeira, F	1

Reviews

5 review(s) available for cyclosporine and Myocardial Ischemia

Article	Year
New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury. Current drug targets, 2017, Volume: 18, Issue:15 Topics: Animals; Antioxidants; Calcium; Cardiotonic Agents; Cyclosporine; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Reactive Oxygen Species	2017
Progress in Therapies for Myocardial Ischemia Reperfusion Injury. Current drug targets, 2017, Volume: 18, Issue:15 Topics: Adenosine; Animals; Atrial Natriuretic Factor; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Disease Models, Animal; Exenatide; Humans; Ischemic Postconditioning; Ischemic Preconditioning; Myocardial Ischemia; Myocardial Reperfusion Injury; Peptides; Venoms	2017
Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. British journal of pharmacology, 2012, Volume: 165, Issue:5 Topics: Animals; Cardiotonic Agents; Cyclosporine; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardium	2012
Potential interest of anti-ischemic agents for limiting cyclosporin A nephrotoxicity. International journal of clinical pharmacology research, 1997, Volume: 17, Issue:4 Topics: Adenosine Triphosphate; Calcium; Creatinine; Cyclosporine; Humans; Kidney; Mitochondria; Myocardial Ischemia; Trimetazidine; Vasodilator Agents	1997
Management issues in renal transplantation. Transplantation proceedings, 1998, Volume: 30, Issue:5 Topics: Bone Diseases; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Joint Diseases; Kidney Transplantation; Myocardial Ischemia; Postoperative Complications; Risk Factors	1998

Trials

1 trial(s) available for cyclosporine and Myocardial Ischemia

Article	Year
Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus. Transplantation proceedings, 2008, Volume: 40, Issue:8 Topics: Adult; Cardiomyopathy, Dilated; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myocardial Ischemia; Patient Selection; Sirolimus; Survival Analysis; Survivors; Tacrolimus; Tissue Donors; Treatment Outcome	2008

Article

Year

Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus.

Transplantation proceedings, 2008, Volume: 40, Issue:8

Topics: Adult; Cardiomyopathy, Dilated; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myocardial Ischemia; Patient Selection; Sirolimus; Survival Analysis; Survivors; Tacrolimus; Tissue Donors; Treatment Outcome

2008

Other Studies

47 other study(ies) available for cyclosporine and Myocardial Ischemia

Article	Year
Cyclosporine-insensitive mode of cell death after prolonged myocardial ischemia: Evidence for sarcolemmal permeabilization as the pivotal step. PloS one, 2018, Volume: 13, Issue:7 Topics: Animals; Cardiotonic Agents; Cell Death; Cell Membrane Permeability; Cyclosporine; Female; Male; Microscopy, Confocal; Myocardial Ischemia; Myocardial Reperfusion Injury; Rabbits; Sarcolemma	2018
Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse. Biochemical pharmacology, 2015, Mar-01, Volume: 94, Issue:1 Topics: Animals; Cardiotonic Agents; Cyclophilins; Cyclosporine; Gene Expression; Heterozygote; Homozygote; Ischemic Postconditioning; Male; Mice; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Oxidative Phosphorylation; Peptidyl-Prolyl Isomerase F; Rats; Signal Transduction; Tissue Kallikreins; Voltage-Dependent Anion Channel 1	2015
Blocking the mitochondrial permeability transition pore with cyclosporine-A can restore cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:3 Topics: Animals; Cyclosporine; Hypercholesterolemia; Ischemic Postconditioning; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Rats; Rats, Wistar	2015
Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore. PloS one, 2016, Volume: 11, Issue:3 Topics: Animals; Atractyloside; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Energy Metabolism; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoquinolines; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Morphine; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Random Allocation; Rats, Wistar; Reperfusion; Signal Transduction; STAT3 Transcription Factor; Sulfonamides	2016
Mitochondrial dysfunction in H9c2 cells during ischemia and amelioration with Tribulus terrestris L. Life sciences, 2016, May-01, Volume: 152 Topics: Antioxidants; Cell Line; Coumaric Acids; Cyclosporine; Diosgenin; Electron Transport; Fruit; Glutathione; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Mitochondrial Diseases; Myocardial Ischemia; Phlorhizin; Plant Extracts; Tribulus	2016
Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition. The Annals of thoracic surgery, 2008, Volume: 86, Issue:4 Topics: Analysis of Variance; Animals; Calcineurin; Cyclosporine; Disease Models, Animal; Immunohistochemistry; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Muscle; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Probability; Rabbits; Random Allocation; Sensitivity and Specificity; Tacrolimus	2008
Invited commentary. The Annals of thoracic surgery, 2008, Volume: 86, Issue:4 Topics: Animals; Cyclosporine; Disease Models, Animal; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Rabbits; Sensitivity and Specificity; Tacrolimus	2008
Mitochondrial OPA1, apoptosis, and heart failure. Cardiovascular research, 2009, Oct-01, Volume: 84, Issue:1 Topics: Animals; Apoptosis; Cell Line; Cyclosporine; Cytochromes c; GTP Phosphohydrolases; Heart Failure; Humans; Membrane Proteins; Membrane Transport Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Proteins; Myocardial Ischemia; Rats; RNA, Messenger	2009
Cyclosporin a in reperfusion injury: not opening to cell death knocking at the door? The Annals of thoracic surgery, 2010, Volume: 89, Issue:5 Topics: Animals; Cell Death; Cyclosporine; Humans; Intracellular Membranes; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Sensitivity and Specificity	2010
In vivo fluorometric assessment of cyclosporine on mitochondrial function during myocardial ischemia and reperfusion. The Annals of thoracic surgery, 2010, Volume: 89, Issue:5 Topics: Animals; Cyclosporine; Disease Models, Animal; Immunohistochemistry; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Rabbits; Random Allocation; Reference Values; Risk Assessment; Spectrometry, Fluorescence	2010
Mitochondrial uncoupling agents trigger ventricular fibrillation in isolated rat hearts. Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:4 Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cyclosporine; Decanoic Acids; Hydroxy Acids; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Oxidative Phosphorylation; Potassium Channels; Rats; Rats, Sprague-Dawley; Sarcolemma; Ventricular Fibrillation	2011
Protective effects of cyclo(L-Leu-L-Tyr) against postischemic myocardial dysfunction in guinea-pig hearts. Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:3 Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Calcium; Cardiovascular Agents; Caspase 3; Cyclosporine; Dipeptides; Female; Guinea Pigs; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peptides, Cyclic; Structure-Activity Relationship; Ventricular Dysfunction, Left	2011
Ischaemic preconditioning and mitochondrial permeability transition: a long-lasting relationship. Cardiovascular research, 2012, Nov-01, Volume: 96, Issue:2 Topics: Animals; Cyclosporine; Ion Channels; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Myocardial Ischemia	2012
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovascular research, 2002, Aug-15, Volume: 55, Issue:3 Topics: Adenosine; Analysis of Variance; Animals; Atractyloside; Calcineurin Inhibitors; Cyclosporine; Decanoic Acids; Diazoxide; Enzyme Inhibitors; Hydroxy Acids; Ion Channels; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Permeability; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Purinergic P1 Receptor Agonists; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus	2002
[Effect of inductors and inhibitors of the mitochondrial permeability transition pore on its opening and release of unidentified mitochondrial factor]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2003, Volume: 49, Issue:1 Topics: Animals; Arsenicals; Cyclosporine; Guinea Pigs; In Vitro Techniques; Ion Channels; Membrane Proteins; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidative Stress; Rats; Rats, Wistar	2003
Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. Journal of molecular and cellular cardiology, 2003, Volume: 35, Issue:4 Topics: Animals; Caspases; Cell Nucleus; Cyclosporine; Cytochromes c; DNA Fragmentation; Enzyme Activation; Ion Channels; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardium; Rats; Rats, Wistar	2003
Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:7 Topics: Adult; Biomarkers; Blood Glucose; Blood Pressure; California; Cholesterol; Creatinine; Cyclosporine; Diastole; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications; Recurrence; Steroids; Survival Analysis; Systole; Tacrolimus; Time Factors; Treatment Outcome	2003
Mitochondrial membrane potentials in ischemic hearts. Archives of biochemistry and biophysics, 2003, Dec-15, Volume: 420, Issue:2 Topics: Animals; Blood Pressure; Calcium; Cell Membrane Permeability; Cyclosporine; Electrophysiology; Intracellular Membranes; Male; Membrane Potentials; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Onium Compounds; Organophosphorus Compounds; Phosphocreatine; Rats; Rats, Sprague-Dawley; Tritium	2003
Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation, 2004, Apr-13, Volume: 109, Issue:14 Topics: 2,4-Dinitrophenol; Adenosine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Cardiotonic Agents; Cells, Cultured; Cyclosporine; Diazoxide; Electric Conductivity; Ion Channel Gating; Ion Channels; Ion Transport; Ischemic Preconditioning, Myocardial; Lactones; Macromolecular Substances; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Spiro Compounds; Uncoupling Agents; Vasodilator Agents	2004
Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology, 2004, Volume: 100, Issue:3 Topics: Anesthetics, Inhalation; Animals; Calcium; Cyclosporine; Decanoic Acids; Desflurane; Hemodynamics; Hydroxy Acids; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Membrane Proteins; Microscopy, Electron; Mitochondria, Heart; Myocardial Ischemia; Permeability; Potassium Channels; Rabbits	2004
Postconditioning inhibits mitochondrial permeability transition. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Animals; Apoptosis; Calcium; Coronary Disease; Cyclosporine; Extracellular Signal-Regulated MAP Kinases; Ion Channel Gating; Ion Channels; Ion Transport; Male; MAP Kinase Signaling System; Membrane Potentials; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Oxidative Stress; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rabbits; Random Allocation; Time Factors	2005
The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha. Cytokine, 2005, Dec-07, Volume: 32, Issue:5 Topics: Animals; Atractyloside; Coronary Circulation; Cyclosporine; In Vitro Techniques; Ion Channels; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Permeability; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha	2005
[Cyclosporine A as an effective treatment for a patient with acquired hemophilia A complicated with diabetes mellitus and ischemic heart disease]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:10 Topics: Aged; Autoantibodies; Biomarkers; Cyclosporine; Diabetes Complications; Factor VIII; Hemophilia A; Humans; Immunosuppressive Agents; Male; Myocardial Ischemia; Salvage Therapy; Treatment Outcome	2005
Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovascular research, 2006, Sep-01, Volume: 71, Issue:4 Topics: Animals; Calcium; Calcium Channel Blockers; Cell Death; Cell Line; Cells, Cultured; Cyclosporine; Cytosol; Hydrogen-Ion Concentration; Ion Channel Gating; Microscopy, Fluorescence; Mitochondria, Heart; Mitochondrial Swelling; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Ruthenium Red; Voltage-Dependent Anion Channels	2006
Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:12 Suppl 3 Topics: Adult; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Female; Graft Rejection; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Prevalence; Retrospective Studies; Risk Factors; Smoking; Spain	2006
Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovascular research, 2007, Aug-01, Volume: 75, Issue:3 Topics: Animals; Bradykinin; Cyclophilins; Cyclosporine; Diazoxide; Enzyme Inhibitors; Female; Ischemic Preconditioning, Myocardial; Lactones; Male; Mice; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Animal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peptidyl-Prolyl Isomerase F; Spiro Compounds; Vasodilator Agents	2007
Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion. Acta anaesthesiologica Scandinavica, 2007, Volume: 51, Issue:7 Topics: Animals; Blood Pressure; Cardiotonic Agents; Caspase 3; Cyclosporine; Heart Rate; Immunosuppressive Agents; Male; Microscopy, Electron; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley	2007
Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. Journal of molecular and cellular cardiology, 1993, Volume: 25, Issue:12 Topics: Adenine Nucleotides; Amino Acid Isomerases; Animals; Calcium; Carrier Proteins; Cyclosporine; Energy Metabolism; Female; Heart; Intracellular Membranes; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peptidylprolyl Isomerase; Rats; Rats, Wistar; Tacrolimus	1993
Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature. Nephron, 1995, Volume: 70, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins A; Apolipoproteins B; Cardiovascular Diseases; Child; Cholesterol; Cyclosporine; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Gemfibrozil; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Isoenzymes; Kidney; Kidney Function Tests; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Radioimmunoassay; Reference Values; Renal Dialysis; Triglycerides; Ultrasonography	1995
Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. The Biochemical journal, 1995, Apr-01, Volume: 307 ( Pt 1) Topics: Adenosine Diphosphate; Animals; Biological Transport; Calcium; Cyclosporine; Cyclosporins; Deoxyglucose; Female; Intracellular Membranes; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion; Oxygen Consumption; Rats; Rats, Wistar	1995
Endothelin levels after orthotopic heart transplantation. Transplantation proceedings, 1994, Volume: 26, Issue:1 Topics: Adult; Blood Pressure; Cardiomyopathies; Creatinine; Cyclosporine; Endothelins; Female; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Time Factors	1994
Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure: influence of cyclosporine therapy. American heart journal, 1994, Volume: 127, Issue:6 Topics: Analysis of Variance; Blood Vessels; Cardiomyopathy, Dilated; Combined Modality Therapy; Cyclosporine; Female; Forearm; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Myocardial Ischemia; Plethysmography; Time Factors	1994
Heart transplant for the failing ischaemic ventricle. Cardiovascular surgery (London, England), 1996, Volume: 4, Issue:2 Topics: Contraindications; Cyclosporine; Heart Arrest, Induced; Heart Transplantation; Humans; Immunosuppressive Agents; Myocardial Ischemia; Postoperative Complications; Pulmonary Artery; Vascular Resistance	1996
A novel mechanism for cyclosporine: inhibition of myocardial ischemia and reperfusion injury in a heterotopic rabbit heart transplant model. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1996, Volume: 15, Issue:9 Topics: Animals; Blood Pressure; Body Fluids; Cardiovascular Agents; Cyclosporine; Disease Models, Animal; Heart Transplantation; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Time Factors; Transplantation, Heterotopic; Ventricular Function, Left	1996
Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation. Pharmacology, 1996, Volume: 52, Issue:1 Topics: 3,4-Methylenedioxyamphetamine; Analysis of Variance; Animals; Aorta; Coronary Circulation; Cyclosporine; Drug Synergism; Heart; Heart Transplantation; Immunosuppressive Agents; Lipid Peroxidation; Male; Myocardial Ischemia; Pharmaceutical Vehicles; Polyethylene Glycols; Rats; Rats, Wistar; Reactive Oxygen Species; Tachycardia; Ventricular Fibrillation	1996
Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin. Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antirheumatic Agents; Bosentan; Coronary Circulation; Cyclosporine; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Enzyme Inhibitors; Glutathione; Guinea Pigs; Hemodynamics; Immunosuppressive Agents; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; Nitroarginine; Sulfonamides	1997
Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic research in cardiology, 1998, Volume: 93, Issue:2 Topics: Animals; Coronary Vessels; Cyclosporine; Dexamethasone; Embolism; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Immunosuppressive Agents; Macrophages; Male; Microcirculation; Monocytes; Myocardial Ischemia; Necrosis; Swine; Time Factors; Tumor Necrosis Factor-alpha	1998
Effects of ischaemia-reperfusion and cyclosporin-A on cardiac muscle ultrastructure. Histology and histopathology, 1998, Volume: 13, Issue:3 Topics: Animals; Cyclosporine; Female; Heart; Immunosuppressive Agents; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Rats; Rats, Sprague-Dawley	1998
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe? Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:3 Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Glucocorticoids; Head and Neck Neoplasms; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Myocardial Ischemia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Opportunistic Infections; Prednisolone; Skin Neoplasms	1998
Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovascular research, 1998, Volume: 38, Issue:3 Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cyclosporine; Enzyme Inhibitors; Female; Immunosuppressive Agents; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Rabbits; Tacrolimus	1998
The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study. The Canadian journal of cardiology, 1999, Volume: 15, Issue:12 Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cardiovascular Agents; Cyclosporine; Cytomegalovirus Infections; Diltiazem; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications	1999
Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. Circulation research, 2000, Feb-18, Volume: 86, Issue:3 Topics: Adenoviridae; Animals; Animals, Newborn; Apoptosis; Calcineurin; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Cyclosporine; Gene Transfer Techniques; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Proteins; Heart; Humans; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Ultrasonography	2000
Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovascular research, 2000, Volume: 47, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Cyclosporine; Decanoic Acids; Dinitrophenols; Enzyme Inhibitors; Homeostasis; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Myocardial Ischemia; Perfusion; Rats; Rats, Long-Evans; Trimetazidine; Uncoupling Agents	2000
Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. The Journal of biological chemistry, 2001, Jan-26, Volume: 276, Issue:4 Topics: Animals; Cell Death; Cyclosporine; Cytosol; In Vitro Techniques; Ion Channels; Male; Membrane Proteins; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NAD; NAD+ Nucleosidase; Rats; Rats, Wistar	2001
Bacterial endocarditis: a rare complication following orthotopic cardiac transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2001, Volume: 20, Issue:4 Topics: Cyclosporine; Endocarditis, Bacterial; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Intracranial Embolism; Male; Middle Aged; Myocardial Ischemia; Staphylococcal Infections	2001
Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts. Transplantation, 2001, Aug-15, Volume: 72, Issue:3 Topics: Animals; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Myocardial Ischemia; Myocardium; Postoperative Care; Rats; Serine Proteinase Inhibitors; Serpins; Time Factors; Transplantation, Heterologous; Transplantation, Homologous; Viral Proteins	2001
Cardiovascular effects of cyclosporin treatment in an experimental model. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2002, Volume: 21, Issue:2 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Blood Pressure; Creatine Kinase; Cyclosporine; Hypertension; Immunosuppressive Agents; Kidney; Lipids; Male; Models, Animal; Myocardial Ischemia; Rats; Rats, Wistar; Tachycardia	2002